Register entry

Devatis, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
30
Labeller names
2
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

30

30 active NDC listings: 30 human prescription drug. By marketing category: ANDA 30.

Dosage formNDCs
capsule12
injection, solution6
powder, for suspension3
injection2
solution2
tablet, film coated2
emulsion1
injection, powder, for solution1
solution/ drops1
RouteNDCs
oral17
intravenous6
intramuscular3
ophthalmic2
respiratory (inhalation)2
subcutaneous1
Labeller name on the listingNDCs
devatis, inc.16
devatis inc.14
Catalogue

Marketed products

30
BrandGeneric nameForm / routeNDC
Amoxicillin and Clavulanate Potassiumamoxicillin and clavulanate potassiumtablet, film coated, oral73043-006ANDA
Amoxicillin and Clavulanate Potassiumamoxicillin and clavulanate potassiumtablet, film coated, oral73043-007ANDA
Amoxicillin and Clavulanate PotassiumAmoxicillin and Clavulanate Potassiumpowder, for suspension, oral73043-008ANDA
Amoxicillin and Clavulanate PotassiumAmoxicillin and Clavulanate Potassiumpowder, for suspension, oral73043-009ANDA
Arformoterol Tartrate InhalationArformoterol Tartrate Inhalationsolution, respiratory (inhalation)73043-052ANDA
Brimonidine Tartrate and Timolol maleate Ophthalmic SolutionBrimonidine Tartrate and Timolol maleatesolution/ drops, ophthalmic73043-029ANDA
Chlorpromazine hydrochlorideChlorpromazine hydrochlorideinjection, intramuscular73043-048ANDA
Chlorpromazine hydrochlorideChlorpromazine hydrochlorideinjection, intramuscular73043-049ANDA
Cyclosporinecyclosporineemulsion, ophthalmic73043-005ANDA
FUROSEMIDEfurosemideinjection, solution, intravenous73043-022ANDA
FUROSEMIDEfurosemideinjection, solution, intravenous73043-023ANDA
FUROSEMIDEfurosemideinjection, solution, intravenous73043-024ANDA
Formoterol fumarateFormoterol fumarate dihydratesolution, respiratory (inhalation)73043-051ANDA
Isosulfan BlueIsosulfan Blueinjection, solution, subcutaneous73043-093ANDA
LenalidomideLenalidomidecapsule, oral73043-038ANDA
LenalidomideLenalidomidecapsule, oral73043-039ANDA
LenalidomideLenalidomidecapsule, oral73043-040ANDA
LenalidomideLenalidomidecapsule, oral73043-041ANDA
LenalidomideLenalidomidecapsule, oral73043-042ANDA
LenalidomideLenalidomidecapsule, oral73043-043ANDA
Pantoprazole SodiumPantoprazole Sodiuminjection, powder, for solution, intravenous73043-020ANDA
Succinylcholine ChlorideSuccinylcholine Chlorideinjection, solution, intramuscular, intravenous73043-021ANDA
TemozolomideTemozolomidecapsule, oral73043-011ANDA
TemozolomideTemozolomidecapsule, oral73043-012ANDA
TemozolomideTemozolomidecapsule, oral73043-013ANDA
TemozolomideTemozolomidecapsule, oral73043-014ANDA
TemozolomideTemozolomidecapsule, oral73043-015ANDA
TemozolomideTemozolomidecapsule, oral73043-016ANDA
amoxicillin and clavulanate potassiumamoxicillin and clavulanate potassiumpowder, for suspension, oral73043-010ANDA
levocarnitinelevocarnitineinjection, solution, intravenous73043-034ANDA
Compare

Other companies listing lenalidomide

Enquiry

Common questions

Is Devatis, Inc. FDA approved?
Devatis, Inc. holds no registered establishment of its own; 30 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Devatis, Inc. make?
30 products are listed under Devatis, Inc. in the openFDA NDC Directory, most often as capsule; injection, solution; powder, for suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.